Appointment of Joint Brokers

Source: RNS
RNS Number : 2302W
Centamin PLC
17 August 2022
 

17 August 2022

Centamin plc

("Centamin" or "the Company")

LSE: CEY / TSX: CEE

 

APPOINTMENT OF JOINT BROKERS

 

Centamin is pleased to announce the appointments of Joh. Berenberg, Gossler & Co KG ("Berenberg") and Peel Hunt LLP as joint Corporate Brokers to the Company, working alongside BofA Securities and BMO Capital Markets Limited ("BMO"), effective immediately.

 

About Centamin

Centamin is an established gold producer, with a premium listing on the London Stock Exchange and Toronto Stock Exchange. The Company's flagship asset is the Sukari Gold Mine ("Sukari"), Egypt's largest and first modern gold mine, as well as one of the world's largest producing mines. Since production began in 2009 Sukari has produced circa 5 million ounces of gold, and today has a projected mine life of 12 years.

Through its large portfolio of exploration assets in Egypt and West Africa, Centamin is advancing an active pipeline of future growth prospects, including the Doropo project in Côte d'Ivoire, and approximately 3,000km2 of highly prospective exploration ground in Egypt's Arabian Nubian Shield.

Centamin practices responsible mining activities, recognising its responsibility to not only deliver operational and financial performance but to create lasting mutual benefit for all stakeholders through good corporate citizenship.

FOR MORE INFORMATION please visit the website www.centamin.com or contact:

Centamin plc

Michael Stoner, Group Corporate Manager

investor@centaminplc.com

Buchanan

Bobby Morse/Ariadna Peretz/George Cleary

+ 44 (0) 20 7466 5000

centamin@buchanan.uk.com

 

Berenberg

Matthew Armitt / Jennifer Lee

+44 (0) 20 3207 7800

 

Peel Hunt LLP

Ross Allister / David McKeown

+44 (0) 20 7418 8900

 

LEI: 213800PDI9G7OUKLPV84

Company No: 109180

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPUNANRUKUWAAR